Comparison of Futility Monitoring Guidelines Using Completed Phase III Oncology Trials

Clinical Trials - United Kingdom
doi 10.1177/1740774516666502
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

Futility Stopping in Clinical Trials

Statistics and its Interface
Applied MathematicsStatisticsProbability
2012English

Design and Inference in Phase II/III Clinical Trials Incorporating Monitoring of Multiple Endpoints.

English

Toxicity of Phase I Radiation Oncology Trials: Worldwide Experience

2010English

Predictors of Success of Phase II Pediatric Oncology Clinical Trials

Oncologist
Cancer ResearchMedicineOncology
2019English

Immunodynamics: A Cancer Immunotherapy Trials Network Review of Immune Monitoring in Immuno-Oncology Clinical Trials

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2016English

Communication About the Risks and Benefits of Phase I Pediatric Oncology Trials

Contemporary Clinical Trials
MedicinePharmacology
2015English

Phase III Trials of Targeted Anticancer Therapies: Redesigning the Concept

Clinical Cancer Research
Cancer ResearchOncology
2013English

Impact of Safety Monitoring on Error Probabilities of Binary Efficacy Outcome Analyses in Large Phase III Group Sequential Trials

Pharmaceutical Statistics
StatisticsProbabilityPharmacology
2012English

Pharmacogenomics in Early-Phase Oncology Clinical Trials: Is There a Sweet Spot in Phase II?

Clinical Cancer Research
Cancer ResearchOncology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy